If your doctor has recommended a medicine not yet approved in India, Sowaka manages the entire access process — legally, safely, and reliably. All support is coordinated through your treating physician.
Learn how we help patients →Named Patient and Early Access Programs for oncologists, specialists, and institutional pharmacy teams. Sowaka manages all regulatory paperwork, import logistics, and documentation.
See how we work with HCPs →From regulatory strategy to last-mile patient delivery — managed by Sowaka and powered by SowakaOS, our proprietary operating system for scaled access across underserved geographies.
Partner with Sowaka →Direct access to a panel of U.S. and EU national wholesalers and manufacturers.
CDSCO navigation, NOC and import clearance, and full documentation.
GDP-compliant storage and temperature-controlled handling.
Physician and institution engagement to identify eligible patients.
Compliant delivery to hospital or patient, with chain-of-custody confirmation.
Adverse-event intake and safety reporting. (Launching 2026.)
Combines global reach, local presence, and trusted technology to close the access gap of unregistered medicines in underserved countries
A US Wholesale Drug License and a CDSCO-compliant import model under Rule 36
Front-end and back-end operations owned by Sowaka
Direct access to U.S. and EU national wholesalers and manufacturers
Founders with decades in pharmaceutical distribution and commercialization across Asia, the Middle East, Latin America and Africa
A proprietary managed-access platform that turns every case into structured data
Our proprietary managed-access operating system. Every request, order, filing, and delivery in one structured record — and the foundation of our real-world evidence capability.
Platform access and demo — coming in Phase 2.